WendyYvonneChenMD

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
450 Brookline Avenue
Dana Farber Cancer Institute
Boston, MA 02215
Phone+1 617-632-3800

Fax+1 617-632-1930

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1993

PubMed

Lectures

ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer.
2019 ASCO Annual Meeting - 6/1/2019

Other

Postmenopausal hormone therapy and the risk of breast cancer
Chen WY
http://www.uptodate.com/contents/postmenopausal-hormone-therapy-and-the-risk-of-breast-cancer
UpToDate, Wolters Kluwer Health - 2013-03-27
Factors that modify breast cancer risk in women
Chen WY, Costanza ME
http://www.uptodate.com/contents/factors-that-modify-breast-cancer-risk-in-women
UpToDate, Wolters Kluwer Health - 2012-11-15
Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention
Chen WY
http://www.uptodate.com/contents/selective-estrogen-receptor-modulators-and-aromatase-inhibitors-for
UpToDate, Wolters Kluwer Health - 2012-12-20

Does Combination Menopausal Hormone Therapy Increase the Risk of Breast Cancer?November 4th, 2024
Aspirin vs Placebo as Adjuvant Therapy for Breast CancerApril 29th, 2024
Could Aspirin Help Treat Breast Cancer?April 29th, 2024